[INTERVIEW] Insilico Medicine aims to reverse aging and cure cancer — all using AI
Insilico Medicine has pioneered AI-driven drug development with the world's first fully AI-built drug entering human clinical trials. But the ambitions of its founder and CEO, Alex Zhavoronkov, go far beyond that.